Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
about
The generation and function of soluble apoE receptors in the CNSQuantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregationApolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in miceAR, apoE, and cognitive functionCholine: critical role during fetal development and dietary requirements in adultsEnteroviruses in chronic fatigue syndrome: "now you see them, now you don't"Antioxidants: The new frontier for translational research in cerebroprotectionThe liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein ENon-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E proteinSelective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the ratUptake of lipoproteins for axonal growth of sympathetic neuronsLCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteinsApolipoprotein E knockout mice have accentuated malnutrition with mucosal disruption and blunted insulin-like growth factor I responses to refeeding.Measures of anxiety, sensorimotor function, and memory in male and female mGluR4⁻/⁻ mice.Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice.Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry.Transcription factors Zic1 and Zic2 bind and transactivate the apolipoprotein E gene promoter.Early diagnostic indices for the prevention of Alzheimer's disease.Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2.Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.Biological changes associated with healthy versus pathological aging: a symposium review.Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.Genetic dissection of Alzheimer disease, a heterogeneous disorder.Apolipoprotein E in the brain and its role in Alzheimer's disease.Lipoproteins in the central nervous system.Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.Alzheimer's disease: current knowledge, management and researchAge-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus.Apolipoprotein E polymorphisms and concentration in chronic diseases and drug responses.Preventing dementia.Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formationProgressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.Normal genetic variation, cognition, and aging.Function and comorbidities of apolipoprotein e in Alzheimer's disease.Neuroplasticity in Alzheimer's disease.Age and apolipoprotein E ε4 effects on neural correlates of odor memoryApolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies.
P2860
Q21202840-C4121BEF-2CDD-4BAE-958D-3A9A70DF2100Q24291128-6E45BE82-3C49-4114-AFB1-0E02F9B55F4CQ24298652-6863C9CB-F73B-4A36-BB91-FE2384F232CAQ24646534-7A8ACA25-7E27-4062-80C0-7B78E567B201Q24649101-49667C5B-5C29-4795-A006-8F928E749950Q24672286-551FE36F-FDBC-4E49-A52C-FC2CED239D8BQ26863595-11B7F579-5D0B-47AD-8984-A4F1948059DAQ27321301-08CDD9A5-D562-43A8-98AE-B135D0BB0235Q28165456-A5E3C3F7-D804-4672-9EE6-5F9F49DC67D1Q28569838-ABF52C38-1BA1-4A47-86B5-1F73CFDDEBB7Q28578928-DB0B2AD4-717E-44CE-AC4B-FC49AA769079Q28595076-3A7CB6AE-4666-4B9C-940F-29A34EA4A9D8Q30410797-7EC21815-DD30-4195-9058-9BC6EC158FE4Q30455764-5D85FADB-6CD9-4B55-AAA0-425ABFC0BC28Q30473882-843CE68A-FB60-435C-91EF-2D59211FA3A0Q30682249-C638A87C-6543-4EB4-840E-DDF86C05A9A8Q30945386-FBDF35ED-7AC3-4125-92C4-6DE89B9BDAFFQ31919647-E8A43181-66DC-446C-BDCF-029EEC229803Q32063475-1DF5EA43-DC12-4A73-9E48-9D497C8540BEQ32091544-483D88C6-27FE-49FF-B813-3F0087EDEA2CQ33416543-6422C89B-9B72-4162-A4C4-F7794AE3B2A3Q33599089-562DA132-A509-4E5E-8DD6-FA0E9B74D574Q33662063-D1E0861F-95C5-4BFD-B3E1-4092E049013CQ33735332-E34B93CF-4ECD-49AB-82BB-CBFB3573EDD1Q33909158-0FCC4025-E1BE-4483-A17F-5043FA7BB5E8Q33921712-3BDB1DAD-D0AA-4653-B251-79B36E0A319AQ33922696-4A860154-4B8F-4852-8669-AC19E8DF0463Q33998681-CA4DCBFE-11C7-4D3D-9ECB-CD683E87FB8BQ34025936-30F50E17-8927-496E-8C20-4F228090A424Q34080432-68143158-EA56-40FB-BE5F-B6B2B81B996DQ34093070-5CCA019E-E374-4069-A1A4-AC0F9951BE40Q34174220-8861EEC8-17F4-46D2-B246-5FAA5D424B67Q34284146-30B6C360-4B4F-43C2-83D1-AEF4B1EAC6DCQ34287471-258CC9EC-980E-44C7-9F4C-70B036A4E434Q34348323-F242B6A1-1AF4-4DDA-8081-C218458ECAAFQ34411638-25439138-6CB8-4854-909C-A596ACA5696CQ34951817-451DB632-0066-4EE9-AA38-E67977FF6E07Q34976296-683B91D0-5E05-479C-AD9A-C854C2760C58Q35117343-D4730D62-663E-4217-9EBF-F2DDC23B4121Q35118492-AFAEA5D6-0172-4041-BDC5-7BF19BFFAB98
P2860
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
@en
type
label
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
@en
prefLabel
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
@en
P1476
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.
@en
P2093
P304
P356
10.1016/0166-2236(94)90156-2
P577
1994-12-01T00:00:00Z